Welcome to our dedicated page for CARDINAL HEALTH SEC filings (Ticker: CAH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Cardinal Health, Inc. filings document material events for a healthcare distribution and medical products company, including quarterly results, Regulation FD outlook updates and earnings presentation exhibits. The records tie financial reporting to segment performance, capital returns, debt reduction and corporate finance matters such as revolving credit agreements that support the commercial paper program.
Governance filings cover board composition, annual meeting voting results, director and officer transitions, and related compensation or succession disclosures. The company’s 8-K record also includes material definitive agreements, shareholder voting matters, financial covenants, exhibits and other capital-structure disclosures for Cardinal Health’s public-company profile.
Cardinal Health, Inc. (CAH) is identified as the issuer in a notice that officer Aaron Alt plans a Rule 144 sale of company stock. The filing lists a proposed sale of up to 42,000 common shares, tied to equity awards vesting on August 15, 2026. These include 8,133 shares from restricted stock vesting and 33,867 shares from performance unit vesting, with an aggregate market value stated as $9,926,182.69 as of the filing data.
Cardinal Health, Inc. (CAH) reports that company officer Michelle Greene has filed a notice of proposed sale of Cardinal Health common stock under Rule 144. The filing lists 11,650 shares to be sold through Merrill from an account in Columbus, Ohio, with an aggregate market value of $2,746,148.42 as of the filing. The shares derive from equity awards scheduled to vest on August 15, 2026, including restricted stock and performance units. Cardinal Health common shares outstanding are stated as 232,575,728, a baseline figure, not the amount being sold. The expected sale date is listed as August 18, 2026 on the NYSE.
CARDINAL HEALTH INC (CAH) is named as the issuer in a notice of proposed sale of securities filed for the account of officer Deborah Weitzman. The notice covers a planned sale of 7,354 shares of Cardinal Health common stock related to a restricted stock vest dated August 15, 2026, with NYSE indicated as the trading market.
Cardinal Health, Inc. (CAH) is the issuer of common stock for which Jessica Mayer, an officer, has filed notice of a proposed sale under Rule 144. The notice covers 29,436 shares of common stock with an aggregate market value of $6,952,440.89, based on the stated data, with 232,575,728 shares of Cardinal Health common stock outstanding as of the noted reference. The securities relate to multiple restricted stock and performance unit vests from Cardinal Health occurring between March 15, 2022 and August 15, 2026.
Cardinal Health, Inc. (CAH) is the issuer for which officer Stephen Mason filed a notice of proposed sales of company stock under Rule 144. The notice covers up to 35,000 shares of common stock held at Merrill, relating to equity that has vested or is scheduled to vest from restricted stock and performance units. Listed vesting sources include 2,331 shares from restricted stock vesting on June 30, 2025, 6,401 shares from restricted stock vesting on August 15, 2026, and 26,268 shares from performance units vesting on August 15, 2026.
CARDINAL HEALTH INC (CAH) is the issuer of common stock covered by a notice of proposed sale filed for the account of officer Jason Hollar under Rule 144. The notice relates to up to 124,529 shares of common stock to be sold on the NYSE.
The securities include shares arising from a Restricted Stock Vest of 18,961 shares and a Performance Unit Vest of 105,568 shares, each dated 08/15/2026. The filing is a regulatory disclosure of an intended disposition and does not itself execute any sale.
CARDINAL HEALTH INC (CAH) reported insider equity activity by Deborah Weitzman, CEO of the PSS Segment. She received a grant of 7,314 Common Shares tied to restricted share units that vest in three equal annual installments beginning on August 15, 2027. On the same date, 29,759 Common Shares were withheld at $235.17 per share to satisfy her tax withholding obligations arising from the vesting of 12,661 RSUs and 54,823 performance share units. These transactions were not reported as occurring under a Rule 10b5-1 trading plan.
CARDINAL HEALTH INC (CAH) reported that Chief Accounting Officer Mary C. Scherer received a grant of 765 Common Shares on August 15, 2026, representing restricted share units that vest in three equal annual installments beginning August 15, 2027. On the same date, 1,757 Common Shares were withheld and disposed of to satisfy her tax withholding obligations upon the vesting of previously granted RSUs and performance share units, using a reference price of $235.17 per share, which reflects the prior business day’s closing price.
CARDINAL HEALTH INC (CAH) reported equity compensation activity for Chief Human Resources Officer Valerie Christine Pitteroff. On August 15, 2026, she received a grant of 2,977 Common Shares in the form of restricted share units that vest in three equal annual installments beginning on August 15, 2027. On the same date, 1,852 Common Shares were withheld and disposed of at $235.17 per share to satisfy tax withholding obligations arising from the vesting of 1,621 RSUs and 2,610 performance share units; the price reflects the prior business day’s closing price. These transactions were not made pursuant to a Rule 10b5-1 trading plan.
Cardinal Health Inc (CAH) reported that Chief Legal/Compliance Officer Jessica L. Mayer received a grant of 6,378 restricted share units (RSUs), which vest in three equal annual installments beginning on August 15, 2027. On the same date, 25,285 common shares were disposed of through withholding to satisfy her tax withholding obligations related to the vesting of 10,932 RSUs and 46,992 performance share units, valued at a reference price of $235.17 per share. These transactions reflect equity compensation and related tax withholding, not open-market purchases or sales.